L Gayani Tillekeratne
L Gayani Tillekeratne
Assistant Professor of Medicine, Division of Infectious Diseases
Assistant Research Professor, Global Health
Gayani Tillekeratne, MD MSc is an Assistant Professor in the Division of Infectious Diseases and at the Duke Global Health Institute. Her work focuses on the improving the diagnosis and management of acute respiratory tract infections globally, with the goal of improving antimicrobial use for these infections. She is co-director of the Ruhuna-Duke Centre for Infectious Diseases in Sri Lanka and works with colleagues in Southeast Asia and East Africa. She is a co-investigator in several US clinical trials for COVID-19 vaccines and therapeutics. She co-instructs a course on Infectious Disease Epidemiology in Global Settings.
Projects
-
ACTIV-1 (COVID-19 therapeutic trial)
United States
-
RADx-UP CDCC (COVID-19 diagnostics)
United States
-
Partnership for Enhancing Antimicrobial Use in Resource-Limited Settings (PEARL)
Kenya, Sri Lanka, Tanzania
-
Surveillance for severe dengue in southern Sri Lanka
Sri Lanka
-
Novel Diagnostics to Improve Antimicrobial Stewardship for Acute Respiratory Tract Infections in Resource-Limited Settings
Sri Lanka
-
A One Health approach to antibiotic-resistant Enterobacteriaceae in South Asia
Sri Lanka
-
Antibiotic-resistant Enterobacteriaceae in community-acquired urinary tract infections, southern Sri Lanka
Sri Lanka
Publications
-
Rolfe RJ, Shaikh H, Tillekeratne LG. Mass drug administration of antibacterials: weighing the evidence regarding benefits and risks. Infect Dis Poverty. 2022 Jun 30;11(1):77.Weerasinghe NP, Bodinayake CK, Wijayaratne WMDGB, Devasiri IV, Dahanayake NJ, Kurukulasooriya MRP, et al. Direct and indirect costs for hospitalized patients with dengue in Southern Sri Lanka. Bmc Health Serv Res. 2022 May 16;22(1):657.Bodinayake CK, Nagahawatte AD, Devasiri V, Dahanayake NJ, Wijayaratne GB, Weerasinghe NP, et al. Correction: Outcomes among children and adults at risk of severe dengue in Sri Lanka: Opportunity for outpatient case management in countries with high disease burden. Plos Negl Trop Dis. 2022 May;16(5):e0010498.Ko ER, Henao R, Frankey K, Petzold EA, Isner PD, Jaehne AK, et al. Prospective Validation of a Rapid Host Gene Expression Test to Discriminate Bacterial From Viral Respiratory Infection. Jama Netw Open. 2022 Apr 1;5(4):e227299.
See more publications at Scholars@Duke